355 related articles for article (PubMed ID: 8863499)
1. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways.
Casanovas JM; Artigas F
J Neurochem; 1996 Nov; 67(5):1945-52. PubMed ID: 8863499
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
Matos FF; Korpinen C; Yocca FD
Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
[TBL] [Abstract][Full Text] [Related]
4. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
5. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
6. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
9. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
10. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe.
Bosker FJ; Klompmakers A; Westenberg HG
Eur J Pharmacol; 1997 Aug; 333(2-3):147-57. PubMed ID: 9314028
[TBL] [Abstract][Full Text] [Related]
11. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
Pallotta M; Segieth J; Whitton PS
Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
[TBL] [Abstract][Full Text] [Related]
13. Modification of serotonin neuron properties in mice lacking 5-HT1A receptors.
Richer M; Hen R; Blier P
Eur J Pharmacol; 2002 Jan; 435(2-3):195-203. PubMed ID: 11821026
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Piñeyro G; de Montigny C; Blier P
Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
[TBL] [Abstract][Full Text] [Related]
15. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
[TBL] [Abstract][Full Text] [Related]
16. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus--in vitro electrophysiological evidence.
Laaris N; Le Poul E; Hamon M; Lanfumey L
Fundam Clin Pharmacol; 1997; 11(3):206-14. PubMed ID: 9243251
[TBL] [Abstract][Full Text] [Related]
17. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
Matos FF; Urban C; Yocca FD
J Neural Transm (Vienna); 1996; 103(1-2):173-90. PubMed ID: 9026372
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
19. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
Casanovas JM; Lésourd M; Artigas F
Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
[TBL] [Abstract][Full Text] [Related]
20. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
Adell A; Celada P; Artigas F
J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
